Sinco Pharmaceuticals Holdings LtdSinco Pharmaceuticals Holdings Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Drug Retailers

The ESG rating includes 17 United Nations Sustainable Development Goals including: 'Affordable & Clean Energy', 'Responsible Production & Consumption' and 'Life below Water'. Complete ESG analysis of Sinco Pharmaceuticals Holdings Ltd are reached by signing in. Scroll down to the bottom of the page for potential risks for Sinco Pharmaceuticals Holdings Ltd based on sector, geography and marketcap.

Sinco Pharmaceuticals Holdings Ltd in the Drug Retailers industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.

SDG Transparency Score for Sinco Pharmaceuticals Holdings Ltd 

0.0

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Sinco Pharmaceuticals Holdings Ltd 
0.0

Environmental

0.0

Social

0.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Sapporo Clinical Laboratory Inc
8.0
High
2Nihon Chouzai Co Ltd
7.5
High
.........
68PharMerica Corp
0.4
Low
68Rite Aid Corp
0.4
Low
70Sinco Pharmaceuticals Holdings Ltd
0.0
Low
70Cachet Pharmaceutical Co Ltd
0.0
Low
70Camsing Healthcare Ltd
0.0
Low
70Zhejiang Zhenyuan Share Co Ltd
0.0
Low
70d1000 Varejo Farma Participacoes SA
0.0
Low
.........
View the full peer group of 134 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Sinco Pharmaceuticals Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd offer flexible work?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose water use targets?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Sinco Pharmaceuticals Holdings Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Sinco Pharmaceuticals Holdings Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Sinco Pharmaceuticals Holdings Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Sinco Pharmaceuticals Holdings Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Sinco Pharmaceuticals Holdings Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Sinco Pharmaceuticals Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.

Sinco Pharmaceuticals Holdings Limited, an investment holding company, provides marketing, promotion, and channel management services for imported pharmaceutical products and medical devices in China. The company offers Octapharma, a human albumin solution for use in premature infants; Axetine, which is used for the treatment of bacterial infections, including respiratory infections, urinary tract infections, soft tissue infections, gynecological and obstetrical infections, gonorrhea, and other infections, as well as for the prevention of post-surgery infections; and Medocef that is used for the treatment of bacterial infections, such as the infections of the lower respiratory tract comprising pneumonia, urinary tract, bile duct, peritoneum, skin, soft tissue, pelvic area, and sepsis. It also provides Esafosfina, which is used for treating hypophosphatemia and chronic diseases, including alcohol intoxication, malnutrition, and hypophosphatemic respiratory failure; Taurolite, a third generation oral cholic acid drug that is used for the treatment of gallstone diseases; and Tamifil injection for the treatment of metastatic prostate cancer, true precocious puberty, and endometriosis. In addition, the company engages in the purchase and sale of pharmaceutical products; and provides warehouse facilities for pharmaceutical products. The company was founded in 2011 and is headquartered in Chengdu, the People's Republic of China. Sinco Pharmaceuticals Holdings Limited is a subsidiary of Risun Investments Limited.

Sorry!

Failed to process!